Astria Therapeutics (ATXS) Current Assets: 2017-2019
Historic Current Assets for Astria Therapeutics (ATXS) over the last 3 years, with Sep 2019 value amounting to $42.7 million.
- Astria Therapeutics' Current Assets fell 4.07% to $42.7 million in Q3 2019 from the same period last year, while for Sep 2019 it was $42.7 million, marking a year-over-year decrease of 4.07%. This contributed to the annual value of $38.9 million for FY2018, which is 122.84% up from last year.
- According to the latest figures from Q3 2019, Astria Therapeutics' Current Assets is $42.7 million, which was down 9.08% from $47.0 million recorded in Q2 2019.
- Over the past 5 years, Astria Therapeutics' Current Assets peaked at $52.6 million during Q1 2019, and registered a low of $17.5 million during Q4 2017.
- Moreover, its 3-year median value for Current Assets was $38.9 million (2018), whereas its average is $36.2 million.
- Its Current Assets has fluctuated over the past 5 years, first crashed by 45.39% in 2018, then spiked by 193.82% in 2019.
- Quarterly analysis of 3 years shows Astria Therapeutics' Current Assets stood at $17.5 million in 2017, then soared by 122.84% to $38.9 million in 2018, then dropped by 4.07% to $42.7 million in 2019.
- Its Current Assets stands at $42.7 million for Q3 2019, versus $47.0 million for Q2 2019 and $52.6 million for Q1 2019.